Clinical Trials Directory

Trials / Completed

CompletedNCT00163735

Potential Allergens in Wine: Double-blind Placebo-controlled Trial

Potential Allergens in Wine: Double Blind Placebo-controlled Trial and Basophil Activation Analysis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Bayside Health · Other Government
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study is designed to identify whether wines which are produced using the common potential food allergens such as proteins derived from fish, milk or egg are likely to contain sufficient food allergens to cause allergic reactions in susceptible individuals.

Detailed description

Recent international legislation requires labelling of wines made using potentially allergenic food proteins "casein", egg white, isinglass ( fish derived), milk or evaporated milk where "there is detectable residual processing aid". However it is not clear whether the final wine contains concentrations of residual added food proteins that can provoke allergic reactions. Comparison:This study is a double blind, placebo-controlled trial to determine whether adults known to be allergic to eggs, fish, milk and/or nuts exhibit allergic reactions following consumption of Australian commercial wines fined with food allergens.

Conditions

Interventions

TypeNameDescription
DRUGAdministration of wine fined with potential food allergens

Timeline

Start date
2002-08-01
Primary completion
2006-05-01
Completion
2006-05-01
First posted
2005-09-14
Last updated
2013-12-05

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT00163735. Inclusion in this directory is not an endorsement.